C
Cristina Ivan
Researcher at University of Texas MD Anderson Cancer Center
Publications - 197
Citations - 12070
Cristina Ivan is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 51, co-authored 182 publications receiving 9540 citations. Previous affiliations of Cristina Ivan include University of Texas Health Science Center at Houston & Leibniz University of Hanover.
Papers
More filters
Journal ArticleDOI
Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections
Enrique Fuentes-Mattei,Dana Elena Giza,Masayoshi Shimizu,Cristina Ivan,John T. Manning,Stefan Tudor,Maria Ciccone,Maria Ciccone,Osman Aykan Kargin,Osman Aykan Kargin,Xinna Zhang,Pilar Mur,Nayra Soares do Amaral,Meng Chen,Jeffrey J. Tarrand,Florea Lupu,Alessandra Ferrajoli,Michael J. Keating,Catalin Vasilescu,Sai Ching J. Yeung,George A. Calin +20 more
TL;DR: In this article, the authors used reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and immunoassay to detect Kaposi sarcoma-associated herpesvirus (KSHV/HHV-8) infection in patients.
Journal Article
Expression pattern of FGFR2, Grb2 and Plcγ1 acts as a novel prognostic marker of recurrence recurrence-free survival in lung adenocarcinoma.
Zahra Timsah,Jonathan Berrout,Milind Suraokar,Carmen Behrens,Ju-Hee Song,J. Jack Lee,Cristina Ivan,Mihai Gagea,Michael Shires,Xin Hu,Courtney Vallien,Charles V. Kingsley,Ignacio I. Wistuba,John E. Ladbury +13 more
TL;DR: It is shown that fluctuation in the combinatorial expression levels of FGFR2, Grb2 and Plcγ1 modulates cell invasive properties, tumor formation and is linked to recurrence-free survival in 150 lung adenocarcinoma patients.
Journal ArticleDOI
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation.
Federico Virga,Federica Cappellesso,Benoit Stijlemans,Anne Theres Henze,Rosa Trotta,Jonas Van Audenaerde,Ananda S. Mirchandani,Manuel A. Sanchez-Garcia,Jolien Vandewalle,Francesca Orso,Carla Riera-Domingo,Alberto Griffa,Cristina Ivan,Evelien Smits,Damya Laoui,Fabio Martelli,Lies Langouche,Greet Van den Berghe,Olivier Feron,Bart Ghesquière,Hans Prenen,Claude Libert,Sarah R. Walmsley,Cyril Corbet,Jo A. Van Ginderachter,Mircea Ivan,Daniela Taverna,Massimiliano Mazzone +27 more
TL;DR: In this article, a hypoxia-inducible factor 1α-dependent microRNA (miR)-210 up-regulation in monocytes and macrophages upon pathogen interaction was shown.
Journal ArticleDOI
Blockade of cdk7 reverses endocrine therapy resistance in breast cancer
Yasmin M. Attia,Yasmin M. Attia,Samia A. Shouman,Salama A. Salama,Cristina Ivan,Abdelrahman M. Elsayed,Abdelrahman M. Elsayed,Paola Amero,Cristian Rodriguez-Aguayo,Gabriel Lopez-Berestein +9 more
TL;DR: The findings identify CDK7 as a possible therapeutic target for breast cancer whether it is sensitive or resistant to tamoxifen therapy.
Journal ArticleDOI
Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner
Joshua Armenia,Linda Fabris,Francesca Lovat,Stefania Berton,Ilenia Segatto,Sara D'Andrea,Cristina Ivan,Luciano Cascione,George A. Calin,Carlo M. Croce,Alfonso Colombatti,Andrea Vecchione,Barbara Belletti,Gustavo Baldassarre +13 more
TL;DR: An expression profiling approach provides evidence that the CDK inhibitor p27Kip1 regulates miRs expression following cell cycle exit following contact inhibition, and proposes a new role for miR-223 in the regulation of breast cancer progression.